Hospira's TheraDoc™ Infection Control Assistant™ Ranked #1 in Its Category by KLAS for Second Consecutive Year
LAKE FOREST, Ill., March 27, 2014 /PRNewswire/ -- Hospira (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that, for the second consecutive year, its TheraDoc™ Infection Control Assistant™ software has been ranked as the top product in the Infection Control & Monitoring software category in the recently released Best in KLAS Awards 2013: Software and Services Report (more information available at www.theradoc.com). The full report is available at www.KLASresearch.com. The rankings are based on data from customer surveys of North American hospital and clinic executives, administrators, physicians, nurses, clinicians, and other directors and managers interacting with healthcare equipment and infrastructure solutions.
TheraDoc Infection Control Assistant scored the highest overall performance rating in KLAS' Infection Control & Monitoring market segment, demonstrating continued excellence and leadership in serving customers and meeting their expectations.
"Hospira is proud that direct feedback from users has once again led to TheraDoc Infection Control Assistant being recognized for excellence in infection monitoring and surveillance software," said France Pitera, vice president, Clinical Information Technology, Hospira. "The TheraDoc team will continue diligently to ensure that our solutions evolve to meet the changing clinical and reporting needs of healthcare organizations."
The TheraDoc Infection Control Assistant helps infection preventionists improve performance on many of their most significant challenges, including time spent to deliver accurate regulatory reporting, time to identification of healthcare-associated infections (HAIs), time to isolation of patients with infectious diseases and tracking of organism resistance.
"TheraDoc Infection Control Assistant pulls patient data together in a way that enables us to make better clinical decisions based on our criteria," said Cheryl Herbert, R.N., C.I.C., executive director of Infection Prevention at Good Shepherd Medical Center in Longview, Texas. "The system brings in data in real-time, and displays it in a way that is intuitive. This complements our EMR by helping us to perform the kind of proactive surveillance that is so important to helping us get closer to 'zero.'"
The TheraDoc Infection Control Assistant provides infection preventionists with real-time (a matter of seconds) patient data needed to make a valid identification of potential infections, while leaving final determination in the hands of infection preventionists. TheraDoc Infection Control Assistant also delivers powerful tools enabling infection preventionists to configure workflow to their unique needs, develop their own alerts, select from a large library of existing alerts, and automate creation of reports for the National Healthcare Safety Network.
As part of a suite of knowledge modules that make critical patient information and medical knowledge readily available, the TheraDoc Infection Control Assistant is designed to help clinicians proactively survey their patient populations, intervene quickly and appropriately, and improve the quality and safety of patient care.[2,3] TheraDoc™ Clinical Surveillance System™ software also features Pharmacy Assistant™, a robust clinical pharmacy surveillance application providing specialized tools for drug therapy optimization, antimicrobial stewardship management, adverse drug event monitoring and anticoagulation patient population management. For more information, visit www.theradoc.com.
KLAS is a research firm specializing in monitoring and reporting on the performance of healthcare vendors. KLAS' mission is to improve delivery by independently measuring vendor performance for the benefit of its healthcare provider partners, consultants, investors, and vendors. Working together with executives from more than 4,500 hospitals and more than 3,000 clinics, KLAS delivers timely reports, trends, and statistics that provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, medical equipment, and infrastructure vendors.
Hospira, Inc., is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 17,000 employees. Learn more at www.hospira.com.
1 "Best in KLAS Awards 2013: Software and Services Report," January 2014. © 2014 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.
2 Hellinger W, Alvarez S, Brumble L, Keating M, Mendez J, Darracott R, Young E, Smith R, Mentel J. Optimizing antibiotic therapy with computerized integration of hospital information systems and an antibiotic management team (AMT). Poster session presented at: 42nd Annual Meeting of the Infectious Diseases Society of America; 2004 Sep 30-Oct 3; Boston, MA.
3 Pass M, Song X, Mackie K, Perl T. Enhanced Isolation Practices To Improve Patient Safety: Preventing Nosocomial Transmission in a Hospital. Am J Infect Control. 2006 June;34(5):E105-E106.
SOURCE Hospira, Inc.